Monkeypox vaccine - Shanghai Institute Of Biological Products
Alternative Names: Monkeypox vaccineLatest Information Update: 28 Feb 2025
At a glance
- Originator Shanghai Institute of Biological Products
- Class Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Monkeypox
Most Recent Events
- 21 Jan 2025 Preclinical trials in Monkeypox (Prevention) in China (Parenteral) before January 2025
- 21 Jan 2025 Shanghai Institute Of Biological Products plans a phase I trial for Monkeypox (Prevention) in January 2025 (NCT06771479)